Malaysia MDA Automated Re-Registration: MeDC@St 2.0+, July 2026 Switch & CN Trap
Operational guide to Malaysia MDA's Automated Re-Registration Route in MeDC@St 2.0+: six eligibility gates, CN-first sequencing, QMS whitelist, fees, and TAT.
On 10 July 2026, the Medical Device Authority (MDA) under Malaysia's Ministry of Health issued Revision 2 of its Official Announcement and Submission Guide: Introduction of the Automated Re-Registration Route in MeDC@St 2.0+ (initial release 6 July 2026). Re-registration applications submitted on or after 13 July 2026 may use that streamlined pathway in the Medical Device Centralised Online Application System (MeDC@St 2.0+). Applications submitted before 13 July 2026 remain on the normal evaluation route.
The automated route is not a new marketing authorization, not an establishment-licence renewal, and not automatic renewal. FAQ Q1 of the announcement describes it as a pathway that allows eligible registration holders to renew without undergoing the standard evaluation route. The designed flow is: confirm eligibility, create the re-registration application, update only the permitted form sections, pay the Fifth Schedule application fee, pay the Fifth Schedule registration fee, then receive an electronic registration certificate and an updated MDAR listing. MDA still reserves the right to request additional information or conduct further regulatory review.
The expensive operational failure is sequencing. Any active or pending Change Notification (CN) or Change of Ownership (COO) for that device in MeDC@St 2.0+ blocks the automated route. Folding a labelling change, a non-whitelist QMS certificate, or a new biocompatibility report into the re-registration form is not a shortcut; those changes must be approved under MDA/GD/0020 (Change Notification for Registered Medical Device) first.
This guide maps the 13 July 2026 switch, the six cumulative eligibility gates, the QMS whitelist that names US FDA QMSR, Class A versus Class B/C/D form rules, the two turnaround clocks, Fifth Schedule government fees versus CAB and MAR work, and a 4 September 2026 public-register validity-window count that is not an eligibility census.
Direct Answer: Can You Use the Automated Route Today?
If your medical device registration certificate is inside its final 12 months in Malaysia, the file is in one of three states:
Use the automated route if every gate is true:
- The establishment holds a valid Manufacturer Licence or Authorized Representative (AR) Licence.
- The current registration certificate is active and within one year of expiry.
- The device was previously registered via Full Conformity Assessment or Verification.
- The corresponding CAB certificate remains valid, or — if it has expired at submission — you upload a recertification assessment from a registered CAB (Class B/C/D).
- The manufacturer QMS certificate is one of: ISO 13485, MDSAP, US FDA QMSR, or Japan Ministerial Ordinance No. 169 (Class A empty gas cylinders may use ISO 9001).
- No active or pending CN or COO exists for that device in MeDC@St 2.0+.
- Submitted data reflects the latest MDA-approved record, and the certificate is not under rejection, suspension, or cancellation.
- You update only the permitted fields, pay both Fifth Schedule fees, and do not treat MDA's older 30/60-day FAQ as this clock.
Pause and finish a Change Notification first if:
- A CN or COO is already open, or you still need a design, formulation, intended-use, shelf-life, manufacturing-site, or labelling change beyond the assigned MDA registration number and AR particulars.
- The QMS certificate is outside the whitelist.
- Class B/C/D CAB recertification is still outstanding.
Stay on the standard evaluation route if:
- The re-registration application was submitted before 13 July 2026 (it cannot be converted retroactively).
- The original registration was not via Full Conformity Assessment or Verification.
- The certificate is already expired, suspended, cancelled, or under rejection.
Is the Automated Re-Registration Route a New Malaysia Licence, or a MeDC@St Pathway for an Existing Certificate?
It is the second. The route renews an existing medical device registration certificate inside MeDC@St 2.0+. It does not issue a new establishment licence and does not replace Act 737 registration.
| Instrument | What it is | What the 13 July 2026 route does not do |
|---|---|---|
| Product registration certificate (MDAR listing) | Five-year marketing authorization under Regulation 13 of the Medical Device Regulations 2012 | Does not create a new registration number or a new licence type |
| Establishment licence (manufacturer, importer, wholesaler, AR) | Separate Act 737 licence; a valid Manufacturer or AR licence is a prerequisite | Does not renew the establishment licence |
| Standard evaluation-route re-registration | Pre-13 July 2026 filings, and later filings that fail automated-route gates | Does not convert those files onto the automated pathway |
| Hologram security-label programme | Separate post-market anti-counterfeit initiative | Adds no hologram field, fee, or prerequisite in the July 2026 form |
Under FAQ Q3–Q5:
- The medical device registration certificate is valid for five (5) years.
- FAQ Q4: "The validity period will continue from the previous registration certificate." Early filing does not truncate the remaining term.
- FAQ Q5: "The registration number will remain unchanged from the previous registration certificate."
Distinction from establishment-licence renewal
An establishment licence is a different MDA instrument and a different portal workflow. A valid Manufacturer or AR licence is required to start product re-registration; renewing the establishment licence does not renew product certificates. MDA's establishment-licence renewal page is not this route.
Distinction from the 5 August 2026 hologram press release
On 5 August 2026, MDA Chief Executive Ts. Dr. Muralitharan Paramasua issued a press release announcing phased hologram security labels for registered medical devices, citing the pharmaceutical Farmatag programme in place since 2005. That press release promised a ministerial announcement at IMDEC 2026 on 26 August 2026. As of 4 September 2026, no technical circular was identified that attaches hologram artwork, fees, or application rules to product re-registration. The 10 July 2026 automated-route guide contains no hologram field. Do not delay a product-certificate renewal waiting for that programme.
For Malaysia classification, CAB, HSA reliance, and the one-year re-registration button, see the Malaysia MDA Medical Device Registration Guide.
What Are the Six Eligibility Gates, and Why Does a Pending Change Notification Hide the Button?
MeDC@St 2.0+ does not offer the automated route as an open menu. The announcement's Eligibility & General Requirements and FAQ Q6 are cumulative. Fail any gate and the file is not on this pathway.
The six cumulative eligibility gates
| Gate | Official requirement | What fails in practice |
|---|---|---|
| 1. Licensing status | Valid Manufacturer Licence or Authorized Representative (AR) Licence | No standing to create the application |
| 2. Validity window | Current certificate active and within one (1) year prior to its expiration date | MDA/GD/0070 section 6.1: the re-registration button appears one year prior to expiry. An already-expired certificate is outside this route |
| 3. Original conformity route | Previously registered via Full Conformity Assessment or Verification | Other historical routes are not listed as eligible |
| 4. CAB certificate | Corresponding CAB certificate remains valid; if expired at submission, upload a recertification assessment from a registered CAB (Class B/C/D; Class A has no CAB field) | Blank or expired CAB field without recertification stops Class B/C/D |
| 5. No pending CN or COO | No active Change Notification or Change of Ownership for the device in MeDC@St 2.0+ | Concurrent re-registration and CN are not permitted; the automated workflow does not run |
| 6. Data integrity and standing | Data must reflect the latest MDA-approved information; certificate must not be under rejection, suspension, or cancellation | Unapproved changes and sanctioned certificates are out |
The CN-first rule: MDA/GD/0070 section 6.1 is still in force
FAQ Q12 of the July 2026 announcement says the automated-route guide must be read with the latest MDA/GD/0070 (Second Edition, October 2025). Body section 6.1 (the TOC still labels it 4.1) already said:
- The re-registration button appears in MeDC@St one year prior to expiry.
- If a change notification is submitted and approved, the re-registration button can be found on the completed change-notification application.
- The button will not appear if the application is incomplete.
- Concurrent re-registration and change notification are not permitted.
- No changes to existing information unless approved under MDA/GD/0020.
- MeDC@St technical issues go to the MeDC@St Helpdesk.
The July 2026 announcement makes that sequencing operational for the automated pathway. It does not repeal GD/0070.
Decision order if anything about the device, label, manufacturing site, or QMS still needs to change:
- Is the change already approved under MDA/GD/0020? If yes, use the completed CN application as the place GD/0070 section 6.1 puts the re-registration button.
- If the change is not approved, file the CN now and wait. Do not start automated re-registration in parallel.
- If a CN is already pending, the automated route stays closed until MDA issues the CN approval.
- If there is no change and you are inside 365 days of expiry, proceed on the permitted fields and Fifth Schedule fees.
- If you are more than one year from expiry, wait for the button; use the extra time to confirm CAB and QMS validity.
Any pending CN — not only Category 2 or 3 — matches the announcement's "no active or pending Change Notification" gate. CN review time is not a published automated-route SLA; treat it as a sequencing risk against the remaining validity window, not as a 30/60-day promise copied from the older re-registration FAQ.
Which QMS Certificates Does the 10 July 2026 Announcement Accept, Including US FDA QMSR?
Part A (Class A Manufacturer Information) and Part B (Class B/C/D Manufacturer Information) of the announcement require a valid and current QMS certificate. Only the listed types are accepted on this route. Any other QMS certification requires a CN approved before re-registration.
Accepted on the automated route
- ISO 13485
- MDSAP certificate
- US FDA QMSR
- Japan Ministerial Ordinance No. 169
- Class A empty gas cylinders only: ISO 9001
The announcement asks for a current certificate of those types. It does not say that a US FDA establishment-inspection report, a Form 483 close-out, or "QMSR compliance" without a certificate substitutes for the upload. US FDA QMSR is on the whitelist as a named QMS certificate, following FDA's alignment of 21 CFR Part 820 with ISO 13485; it is not a statement that Malaysia registration is FDA clearance.
MDSAP audit mechanics remain on the MDSAP Audit Guide. Listing MDSAP here is only the whitelist fact.
If the manufacturer moved to a national QMS standard that is not on that list, or changed manufacturing site without a prior CN, the automated route is the wrong module.
Permitted Form Edits vs. Technical Changes: Class A vs. Class B, C, and D
The MeDC@St module pre-populates the approved record. The announcement's Part A (Class A, Annex 3 of MDA/GD/0070) and Part B (Class B/C/D, Annex 4) tables control what may be edited. Manufacturer name and address remain locked unless a prior CN approved a site change; the QMS certificate on that same Manufacturer Information section is Update Required.
Class A (Part A)
| Form section | Requirement | What you may actually do |
|---|---|---|
| Medical Device Classification | Non-editable | System-generated from the approved record |
| Product Status Determination | Non-editable | System-generated |
| Medical Device General Information | Non-editable | System-generated |
| Medical Device Grouping | Non-editable | System-generated |
| Additional Requirements | Non-editable | System-generated |
| Manufacturer Information | Update Required | Upload a current whitelist QMS certificate (ISO 9001 only for empty gas cylinders) |
| Pre-Market Clearance / Approval | Update Required (optional) | Updated clearance/approval documents where available |
| Labelling | Update Required | Latest labelling showing the assigned MDA registration number and AR information only |
| PMS & Vigilance | Update Required | Latest PMS records for the preceding registration period (Annex 3 of MDA/GD/0070) |
| Declaration of Conformity | Update Required | Updated DoC |
Class A has no CAB section.
Class B, C, and D (Part B)
| Form section | Requirement | What you may actually do |
|---|---|---|
| Medical Device Classification | Non-editable | System-generated |
| Medical Device General Information | Update Required (certain fields only) | Device Meant for Export Only; Combination Product status (with NPRA AR/EL); formulation for devices containing registered active ingredients, poisons, or drugs. All other general-information fields stay locked |
| Medical Device Grouping | Non-editable | System-generated. Adding or deleting models is a CN |
| CSDT | Update Required (certain fields only) | Updated CER/CPR; labelling showing the MDA registration number and AR information; latest risk analysis. For IVD cluster grouping, update Section 3 in the form. Other CSDT fields, including new biocompatibility, stability, or validation reports, are not this route |
| Manufacturer Information | Update Required | Current whitelist QMS certificate (no ISO 9001 exception) |
| Pre-Market Clearance / Approval | Update Required (optional) | Updated documentation where available |
| CAB | Update Required / Non-editable | Recertification assessment if the CAB certificate has expired; non-editable if still valid |
| PMS & Vigilance | Update Required | Latest PMS records (Annex 4 of MDA/GD/0070) |
| Declaration of Conformity | Update Required | Updated DoC |
FAQ Q8 and Q10: only designated fields may be updated. Biocompatibility, stability, or validation reports that reflect a change to the registered device must be approved via CN before automated re-registration. Uploading redesigned artwork with new claims, storage conditions, or indications is not "labelling update required"; it is a CN.
What Fails If You Quote the Old 30/60-Day FAQ, Treat Fifth Schedule Ringgit as MAR Fees, or Count MDAR Rows as Eligible Files?
Failure mode 1: quoting the older 30/60-day FAQ as the automated clock
The older official FAQ For Re-Registration still publishes:
- Class A re-registration: 30 days
- Class B, C, and D: 60 days
The Malaysia 101 Timelines Summary still lists 14–20 / 30–60 working days for initial Class A and CAB/MDA review. Those figures are not the automated-route clock.
FAQ Q7 of the 10 July 2026 announcement states:
There is no prescribed regulatory review timeline. Processing time is dependent on the applicant successfully completing the required steps.
If every gate is met and both fees are paid, the flowchart proceeds to electronic-certificate issuance and MDAR listing without a published MDA evaluation queue. That is not a guaranteed same-day or "hours" service level. The same announcement's NOTE says MDA may request additional information or conduct further review. Do not quote 30 or 60 days — or a three-to-five-month evaluation-route anecdote — to a distributor as the automated-route clock.
Failure mode 2: treating Fifth Schedule ringgit as total project cost
FAQ Q9 lists government application and registration fees under the Fifth Schedule of the Medical Device Regulations 2012 and the Medical Device (Amendment) Regulations 2025. They are not:
- CAB recertification invoices. Class B/C/D still need a valid CAB certificate or a recertification assessment from a registered CAB. Those are private commercial fees. Typical ranges used elsewhere on this site for CAB technical review are commercial estimates, not Fifth Schedule lines; see the Malaysia MAR pricing guide.
- MAR professional fees. Portal work, CN sequencing, and post-market liaison are provider or internal costs.
Failure mode 3: counting public MDAR rows as eligible files
A 4 September 2026 extract of the public Malaysia Medical Device Register contained 49,998 unique registration numbers. 5,838 of those listings (11.68%) have expiry dates from 4 September 2026 through 4 September 2027 inclusive.
| Registration-number prefix in that one-year window | Listings | Share of the 5,838 |
|---|---|---|
| GA | 2,259 | 38.7% |
| GB | 1,097 | 18.8% |
| GC | 856 | 14.7% |
| IVD-prefixed (IVD, IVDA, IVDB, IVDC, IVDD) | 682 | 11.7% |
| GMD | 576 | 9.9% |
| GD | 368 | 6.3% |
Calendar split inside the same window: 1,682 expire in the remainder of calendar 2026; 4,156 expire from 1 January 2027 through 4 September 2027. Zero listings in that extract had an expiry date before 4 September 2026.
Limitations. Prefixes are public registration-number labels, not a confirmed risk-class census from MDA's public listing columns. The public register does not show pending CN/COO flags, CAB validity, establishment-licence status, or QMS certificate type. 5,838 is a validity-window count, not the number of files that will pass the automated-route gates. It also should not be reconciled as an error against this site's June 2026 establishment-concentration analysis (49,198 rows as of 6 June 2026); that is a different snapshot and method.
What Does This Cost: Fifth Schedule Application and Registration Fees vs. CAB and MAR Work
Statutory fees on this route are the Fifth Schedule amounts, as amended by P.U.(A) 330 (in force 1 January 2026). P.U.(A) 330 changed the Class A application fee from RM 100 to RM 500 and replaced the Class A registration hyphen with RM 750. FAQ Q9 reprints the consolidated table payable in MeDC@St, including Combination Product.
Statutory government fees (FAQ Q9)
| Risk class / type | Application fee | Registration fee | Total government fee | Source basis |
|---|---|---|---|---|
| Class A | RM 500 | RM 750 | RM 1,250 (~USD 280) | Fifth Schedule; P.U.(A) 330 |
| Class B | RM 250 | RM 1,000 | RM 1,250 (~USD 280) | Fifth Schedule; FAQ Q9 |
| Class C | RM 500 | RM 2,000 | RM 2,500 (~USD 560) | Fifth Schedule; FAQ Q9 |
| Class D | RM 750 | RM 3,000 | RM 3,750 (~USD 840) | Fifth Schedule; FAQ Q9 |
| Combination Product | RM 750 | RM 5,000 | RM 5,750 (~USD 1,290) | Fifth Schedule; FAQ Q9 |
Approximate USD figures use ~4.45 MYR per USD as of 4 September 2026 for board-level comparison only. MeDC@St collects ringgit. These USD amounts are not an official MDA conversion and are not a guaranteed invoice.
Three cost tiers (do not collapse them)
- Government fees — Fifth Schedule application then registration, paid to MDA through MeDC@St. Source: FAQ Q9 and P.U.(A) 330 for the Class A line.
- CAB recertification — private commercial agreement with a registered CAB (Class B/C/D). Not a Fifth Schedule line; not a US FDA MDUFA fee.
- MAR / internal RA work — compiling the permitted uploads, paying, and watching CN/CAB sequencing. Price that from your MAR contract or the MAR pricing guide, not from FAQ Q9.
Country-level context: Medical Device Registration Cost by Country.
Automated Re-Registration 30/60/90-Day SKU Map: Expiry Window, CN Queue, CAB Recertification, and Fee Payment
The statutory window is one year, not 90 days. Start CN clearance and CAB recertification when the button appears. Use the last 90 days only as a last-mile execution plan for files that already have a clean docket.
As soon as the one-year button appears
- Confirm the Manufacturer or AR licence will remain valid through issuance.
- Close or freeze non-essential CN/COO work so Gate 5 stays clear.
- Confirm the QMS certificate is on the whitelist and still in date.
- Class B/C/D: if the CAB certificate will expire before submission, commission recertification now.
Days 90–61 before expiry (last-mile audit)
- Confirm the re-registration button is visible.
- If a CN is still pending, you are not on the automated route; escalate CN, do not pay Stage 1 hoping the button appears.
- Match pre-populated grouping and model tables to the approved record.
Days 60–31 before expiry
- Upload the renewed QMS certificate.
- Class B/C/D: attach recertification if the CAB field is Update Required; do not try to edit a still-valid CAB field.
- Restrict labelling uploads to the MDA registration number and AR particulars.
- Prepare CER/CPR, risk analysis, PMS, and DoC updates required by Part B.
Days 30–0 before expiry
- Submit the application and pay the application fee.
- Complete the permitted form updates.
- Pay the registration fee. The flowchart issues the electronic certificate and updates MDAR after that payment — subject to MDA's right to request further information.
- Confirm the new expiry date on public MDAR.
Checklist:
- Establishment licence will not expire mid-process.
- No open CN/COO for that registration number.
- CAB recertification report in hand before Stage 1 if the certificate has lapsed.
- Payment channel ready (the certificate issues only after Stage 2 settlement).
Regional Regulatory Context: ASEAN Comparison
Malaysia's automated product-certificate route is not the same legal instrument as a neighbour's renewal rule. Confirm each cell against that authority's current text before using it in an SOP.
| Country & authority | Authorization | Validity | Filing window | While a renewal is pending |
|---|---|---|---|---|
| Malaysia (MDA) | MDAR registration | 5 years | Button appears 1 year prior (GD/0070 6.1) | Automated route: no prescribed review timeline (FAQ Q7); evaluation-route files stay on the older clock |
| Philippines (FDA / CDRRHR) | CPR | 5 years | 90 days prior (AO 2018-0002) | Advisory 2026-1007: CPR may remain valid pending decision if filed within 120 days of original expiry and fees/surcharges are paid |
| Singapore (HSA) | SMDR | Listing maintained by annual retention | Annual MEDICS / CRIS retention | Retention paid before the anniversary keeps the listing; this is not a five-year dossier re-review |
| Thailand (Thai FDA) | Registration / notification | Typically 5 years | Confirm the current Thai FDA circular; commonly several months prior | Temporary continuation depends on that circular, not on Malaysia's FAQ Q7 |
| Indonesia (Kemenkes) | NIE / AKL / AKD | Up to 5 years | Confirm current Regalkes rules (often months prior) | Requires a valid local authorization; not an MDA automated issuance |
Broader maps: Southeast Asia ASEAN Registration Guide, ASEAN AMDD CSDT Guide, and the ASEAN distributor qualification matrix.
Frequently Asked Questions (FAQ)
If our certificate expires in six months and we have no pending CN, can we use the automated route today?
If the certificate is active and inside the one-year window, no CN/COO is pending, the original route was Full CA or Verification, the establishment licence is valid, the QMS certificate is on the whitelist, and Class B/C/D CAB status is valid or recertified, then yes — this is the fact pattern FAQ Q6 describes. Still complete the Update Required fields (QMS, labelling, PMS, DoC, and Class B/C/D CSDT limited fields). The automated route is not a zero-upload click.
Do we still need a valid CAB certificate after the automated route issues the new registration?
Yes. FAQ Q11: registration holders are responsible for ensuring that conformity-assessment status remains valid throughout the registration certificate's validity period. If the CAB certificate has expired at submission, upload a recertification assessment from a registered CAB; if it is still valid, the field is non-editable. After issuance, subsequent CAB updates go through Change Notification. MeDC@St 3.0 CAB-direct upload is described as future work; further announcements will be made. Allowing CAB status to lapse is a post-market standing problem under Act 737. FAQ Q11 does not itself recite automatic cancellation on the day of lapse.
Did the 13 July 2026 route repeal MDA/GD/0070's one-year button and no-concurrent-CN rules?
No. FAQ Q12 requires the announcement to be read with the latest MDA/GD/0070. Section 6.1 still hides the button until one year prior, still forbids concurrent CN, and still sends an approved CN's re-registration button to the completed CN application.
Is the older MDA FAQ's 30-day Class A / 60-day Class B-C-D turnaround the automated-route clock?
No. Those figures remain on the older FAQ For Re-Registration for the evaluation-style process. FAQ Q7: there is no prescribed regulatory review timeline; processing time depends on the applicant completing the required steps. MDA may still request more information.
Are the RM 500–5,000 Fifth Schedule amounts the only costs, or do CAB and MAR bills still apply?
They are only MDA application and registration fees (FAQ Q9 / P.U.(A) 330). CAB recertification and MAR work remain separate commercial lines. The FAQ Q9 table tops out at RM 5,000 registration for Combination Product (RM 750 + RM 5,000 = RM 5,750 government total), not "RM 5,000 all-in."
Does the hologram security-label press release of 5 August 2026 change how we re-register?
No. The 5 August 2026 press release is a different instrument. The automated-route guide has no hologram field, fee, or prerequisite. Do not park a one-year-window file waiting for hologram instructions.
How Pure Global Supports Malaysia Medical Device Lifecycle & Regulatory Compliance
Maintaining continuous market authorization in Malaysia requires licence tracking, CN sequencing, and fluency with MeDC@St — not a second reading of the MDA PDF.
Pure Global provides regulatory affairs, in-country Malaysian Authorized Representative (MAR) licensing, and lifecycle compliance management for medical device and IVD manufacturers.
- Malaysia Authorized Representative (MAR) services: Independent in-country representation holding the establishment licence, with fee structures in the global regulatory pricing directory.
- Automated re-registration execution: Portfolio checks against the six eligibility gates, the QMS whitelist, and the CN-first rule, through the Malaysia regulatory team.
- Change Notification and CAB sequencing: MDA/GD/0020 filings coordinated with registered CABs so an open CN does not hide the one-year button.
- Pan-ASEAN dossier reuse: Aligning Malaysian CSDT updates with parallel Singapore, Philippines, Thailand, and Indonesia maintenance where the legal instruments actually match.
To audit a Malaysian portfolio or run a MeDC@St 2.0+ re-registration, contact Pure Global's regulatory affairs specialists.
Pure Global provides independent commercial regulatory affairs, in-country authorized representation, and quality compliance advisory services. Pure Global is not the Medical Device Authority (MDA) of Malaysia, the Ministry of Health Malaysia (KKM), a registered Conformity Assessment Body (CAB), or the Royal Malaysian Customs Department.